Cyrus Khan is an Oncology physician affiliated with Allegheny Health Network. OpenAlex indexes 101 publications with 1,145 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
144 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
144 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
31.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor31.6%Acyclovir100%Part D≥47 patientsCancer & immunology
21%Kinase inhibitor13.4%Jakafi33%Calquence21%Brukinsa15%Tasigna13%Bosulif10%Jaypirca9%Part D<11 patientsBCL-2 Inhibitor6.2%Venclexta100%Part D≥19 patients+ 1 more class in this area
Nervous system
11.6%Opioid Agonist6.1%Oxycodone Hcl51%Tramadol Hcl26%Oxycodone-Acetaminophen23%Part D<11 patientsPhenothiazine3.2%Prochlorperazine Maleate100%Part D≥17 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ABCL-865: Post–CAR-T Therapy Relapse in Diffuse Large BCell Lymphoma: Real-World Salvage Therapy Patterns and Outcomes at a Tertiary Academic Center
Clinical Lymphoma Myeloma & Leukemia
2026 - A rare case of chronic lymphocytic leukemia complicated by myasthenia gravis
Journal of Community Hospital Internal Medicine Perspectives
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Manzi, MD
Allegheny Health Network
Sushil Beriwal, MD
Allegheny Health Network
Srinivas Murali, MD
Allegheny Health Network
Hiran Fernando, MD
Allegheny Health Network
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”